Image Image Image Image Image Image Image Image Image Image
إمكانية الوصول
اذهب للأعلى

اذهب للأعلى

Clinical trial in antiretroviral-naive patients with choroidal neovascularization secondary to AMD
19/03/2014

DMAE atrofica

 

Description

A phase 4, multi-centre, three-arm, randomised, open-label [SF1] clinical trial lasting 12 months, to evaluate the efficacy and safety of two treatment systems: the bimonthly or individualised flexible PRN “treat-and-extend” regimen; versus a PRN regimen of intravitreal injections of Ranibizumab 0.5 mg in keeping with stabilisation criteria based on monthly controls [SF2] in antiretroviral-naive patients with choroidal neovascularization secondary to age-related macular degeneration. An IN-EyE study.

 

EmmaOro_red2

If you are interested in taking part in a clinical trial, please fill in this form to contact us or call +34 935 950 155

Our team of professionals will answer you as soon as possible and we will assess whether you are eligible. 

الحقن داخل الجسم الزجاجيالتنكّس البقعي المرتبط بالعمر الرطب/النتحي (Exudative ARMD)

Author

الدكتور جوردي مونيس، دكتوراة في الطب
سجل نقابة الأطباء (COMB: 22.838)
مدير
دكتور في الطب والجراحة
أخصائي طب العيون
أختصاص في الشبكة والبقعة والجسم الزجاجي

Last modified: 11 June, 2019 - 8:44